App-Quantinova.ai

Parenteral Iron Sucrose Improves Iron Biomarkers in Pediatric Heart Failure Patients With Iron Deficiency

Michael J Lin - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

Iron sucrose

Cluster Analysis of Cardiac Resynchronization Response Parameters Predicts Long-Term Survival With Heart Failure

Kenneth C Bilchick - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Racial Differences in Cardiometabolic Determinants of Natriuretic Peptide Levels in Clinically Referred Patients With and Without Heart Failure

Newman Kwame Boakye Ansa - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Development of a Novel Biomarker-based Risk Score for Heart Failure in Patients With Diabetes

David D Berg - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Congestive heart failure

Dapagliflozin

The Prevalence and Predictors of Transthyretin Amyloidosis in Patients Underwent Transcatheter Aortic Valve Implantation

Yuki Muto - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Amyloidosis, transthyretin-related

N/A

Proinflammatory Diet Independently Predicts Shorter Event-free Survival in Patients With Heart Failure

Junghee Kang - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

Angiotensin II

Acute Phase Predictors for In-hospital Mortality and Chronic Thromboembolic Pulmonary Hypertension in Acute Pulmonary Embolism Patients

Megumi Yamamuro - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic thromboembolic pulmonary hypertension

Heparin

Cardio-ankle Vascular Index Predicts New Onset Stroke in Patients With Heart Failure

Yu Hotsuki - American Heart Association (AHA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Chronic obstructive pulmonary disease

N/A

Responses and Cardiotoxicity with R-CDOP and R-CHOP Observed in Frontline Therapy for Patients with Primary Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Randomized Phase-IV Study from Multiple Centers in China

Lili Feng - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Diffuse large B-cell lymphoma

Cyclophosphamide

Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed By Autologous Stem Cell Transplantation for AL Amyloidosis: Long Term Follow-up Analysis

Vishal K Gupta - American Society of Hematology (ASH) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

AL Amyloidosis

Dexamethasone

Maternal hemodynamics using the Nexfin device in preeclampsia compared with normal pregnancy

Lili Sheibani - Society for Maternal-Fetal Medicine (SMFM) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Preeclampsia

Magnesium sulfate

Can noninvasive continuous hemodynamic monitoring reliably differentiate preeclampsia from the normotensive state?

Lili Sheibani - Society for Maternal-Fetal Medicine (SMFM) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Preeclampsia

Magnesium sulfate

Is N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) disturbed in polycystic ovary syndrome?

Malgorzata Kaluzna - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Polycystic Ovary Syndrome

Androgen Tear

"The prognostic efficiency of the N-terminal fragment of the Brain natriuretic peptide in the diagnosis of chronic heart failure in patients with type 2 diabetes”

Zamira Khalimova - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Type 2 diabetes mellitus

N/A

Renal and Cardiac Effects of Remote Ischemic Preconditioning in Children Undergoing Cardiopulmonary Bypass Surgery

Yuk M Law - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Correlates of Sleep Disordered Breathing and Cheyne-Stokes Respiration in Patients With Atrial Fibrillation Undergoing Pulmonary Vein Isolation

Akihiro Sato - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Prognostic Value of Right Ventricular Longitudinal Strain in Transthyretin Amyloid Cardiomyopathy

Hiroki Usuku - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Transthyretin cardiac amyloidosis

N/A

MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2 INFECTION AND E.COLI SEPSIS: THE POTENTIAL ROLE OF PROCALCITONINE AS A RAPID DIAGNOSTIC BIOMARKER TO DISTINGUISH TWO DIFFERENT PHASES OF SYSTEMIC INFLAMMATORY RESPONSE SYNDROME

M. Gilio - European League Against Rheumatism (EULAR) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Systemic inflammatory response syndrome

Methylprednisolone

CURRENT CARDIOVASCULAR DISEASE RISK PREDICTION MODELS ARE NOT APPLICABLE IN MDS PATIENTS: PRELIMINARY RESULTS OF A PROSPECTIVE OBSERVATIONAL SINGLE-CENTRE COHORT STUDY

Christina Misidou - European Hematology Association (EHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Systemic inflammation

N/A

SERIAL ASSESSMENT OF BIOMARKERS AND THE RISK OF HEART FAILURE IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ENGAGE AF-TIMI 48 TRIAL

Kazuma Oyama - American College of Cardiology (ACC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Edoxaban

Filters

387 Abstracts